Results 221 to 230 of about 4,313,369 (257)

The cumulative effect of multiple high-sugar and high-fat dietary patterns on acne vulgaris in school aged children: a cross-sectional study in Shanghai. [PDF]

Front Public Health
Cai R, Qiang Y, Lu J, Mo M, Ma X, Shen F, Zhang R, Gao X, Wang R.   +8 more
europepmc   +1 more source

Real‐World Efficacy and Systemic Immune Modulation Upon Tralokinumab Treatment in Atopic Dermatitis

Clinical and Translational Allergy, Volume 16, Issue 9, September 2026.
ABSTRACT Background Tralokinumab, an interleukin‐13 (IL‐13) monoclonal antibody, has shown clinical efficacy in randomized trials for moderate‐to‐severe atopic dermatitis (AD). This study aims to evaluate clinical and immunological outcome upon tralokinumab treatment in a real‐world cohort of patients with moderate‐to‐severe AD. Methods We recruited 81
Meslina Almaci, Philipp Globig, Davender Redhu, Margitta Worm   +3 more
wiley   +1 more source

Serum cardiotrophin-1 and interleukin-17 levels are elevated and correlate with disease severity in acne vulgaris. [PDF]

Ir J Med Sci
Sengul-Bag F, Akyurek F, Tuncez-Akyurek F, Saylam-Kurtipek G.   +3 more
europepmc   +1 more source

Empirical Evidence for the Developmental Origins of Autonomic Stress Regulation: An Attachment Account

Developmental Psychobiology, Volume 68, Issue 5, September 2026.
ABSTRACT The quality of the developmental context is proposed to calibrate lifelong stress regulation. Integrating attachment theory with the adaptive calibration model, we tested whether adults exhibit distinct autonomic stress profiles and whether profile membership is associated with attachment security.
Stefania V. Vacaru, Victoria L. Zhu, Greeshma Giridas, Lukas Spiess, Aicha Mazrina, Theodore E. A. Waters   +5 more
wiley   +1 more source

Association Between Willingness to Pay and Quality of Life in Acne Patients: A Cross-Sectional Study with a Nomogram for Individualized Prediction. [PDF]

Clinicoecon Outcomes Res
Li X, Cen X, Ning N, Li C, Zhu Y, Liu J, Zhu Q, He S, Guan Y.   +8 more
europepmc   +1 more source

Adapalene‐Associated Cutaneous Adverse Events: A Disproportionality Analysis of the FAERS Database

Journal of Cosmetic Dermatology, Volume 25, Issue 10, October 2026.
Zhongping Cao, Chenyu Zhao
wiley   +1 more source

Anti‐Müllerian Hormone and Metabolic–Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population‐Based Study

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
In this population‐based study of 883 women, AMH declined less with age in women with PCOS than in healthy women. Higher AMH may protect older healthy women from T2DM but indicates elevated metabolic risk in younger women with PCOS, supporting its role as a life‐course biomarker for metabolic risk stratification.
Fahimeh Ramezani Tehrani, Maryam Mousavi, Marzieh Saei Ghare Naz, Maryam Farahmand, Masoumeh Jorjani, Fatemeh Mahboobifard   +5 more
wiley   +1 more source

Microneedling Versus Chemical Peels for Atrophic Acne Scars: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Agu-Jefferson I, Gebregiorgis TT, Ozumba L, Atoe-Imagbe OM, Ilesanmi ON.   +4 more
europepmc   +1 more source

Plant Flavonoid—Enriched Functional Foods for Polycystic Ovary Syndrome: Dietary Sources, Bioavailability Enhancement, and Personalized Intervention Strategies

Food Science &Nutrition, Volume 14, Issue 9, September 2026.
Plant flavonoids from fruits, vegetables, tea, and soybeans require food processing technologies (microencapsulation, nano‐encapsulation, lipid carriers, fermentation, food collaboration) to enhance bioavailability, enabling the development of functional foods for precision dietary intervention in PCOS.
Jianding Wang, Hejian Zhu, Qing Shen, Yinghua Zhong, Yunli Du, Wenxi Yu, Fang Mao, Zhitao Yao, Weiwei Zhu, Lirong Sun, Qiu Lin, Xiaomin Xu, Jiong Zhu   +12 more
wiley   +1 more source

Lactoferrin as a Novel Therapeutic Agent in Dermatology: Current Evidence and Future Perspectives. [PDF]

Clin Cosmet Investig Dermatol
Zhang H, He X, Chen P, Shen S, Liu Q, Bi X.   +5 more
europepmc   +1 more source